RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-12.08%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.42B
AUM Growth
+$2.42B
(-24%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-7.21%
Top 10 Holdings %
Top 10 Hldgs %
25.87%
Holding
146
New
14
Increased
42
Reduced
23
Closed
13
Top Buys
| 1 |
Biogen
BIIB
|
$56.9M |
| 2 |
Centene
CNC
|
$30.9M |
| 3 |
Applied Therapeutics
APLT
|
$27M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$20.8M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$15M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$106M |
| 2 |
UnitedHealth
UNH
|
$72.6M |
| 3 |
Johnson & Johnson
JNJ
|
$59.3M |
| 4 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$35.2M |
| 5 |
MDCO
Medicines Co
MDCO
|
$26.1M |
Sector Composition
| 1 | Healthcare | 95.03% |
| 2 | Consumer Staples | 1.05% |
| 3 | Consumer Discretionary | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Theravance Biopharma
TBPH
$691M
| $17.3M | 0.72% |
750,000
+94,800
| +14% | +$2.19M |
|
52
Madrigal Pharmaceuticals
MDGL
$9.7B
| $16.7M | 0.69% |
250,000
-200
| -0.1% | -$13.4K |
|
53
Acadia Healthcare
ACHC
$2.15B
| $16.5M | 0.68% |
900,000
-75,000
| -8% | -$1.38M |
|
|
NVTA
54
DELISTED
Invitae Corporation
NVTA
| $15.7M | 0.65% |
1,150,000
-50,000
| -4% | -$684K |
|
55
HealthEquity
HQY
$8.26B
| $15.4M | 0.64% |
305,000
+100,000
| +49% | +$5.06M |
|
56
Adaptive Biotechnologies
ADPT
$1.96B
| $15.1M | 0.63% |
545,000
| – | – |
|
|
GBT
57
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.3M | 0.59% |
280,000
+15,000
| +6% | +$766K |
|
|
IMMU
58
DELISTED
Immunomedics Inc
IMMU
| $14.2M | 0.59% |
1,050,000
+50,000
| +5% | +$674K |
|
|
DCPH
59
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $13.8M | 0.57% |
335,000
-86,890
| -21% | -$3.58M |
|
|
60
Johnson & Johnson
JNJ
$429B
| $13.8M | 0.57% |
105,000
-452,500
| -81% | -$59.3M |
|
61
Guardant Health
GH
$8.11B
| $13.2M | 0.55% |
190,000
| – | – |
|
|
KRTX
62
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $13M | 0.54% |
180,000
| – | – |
|
|
RDUS
63
DELISTED
Radius Health, Inc.
RDUS
| $12.7M | 0.52% |
975,000
-25,200
| -3% | -$328K |
|
|
PTLA
64
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $12.5M | 0.52% |
1,751,900
+851,900
| +95% | +$6.07M |
|
65
Inspire Medical Systems
INSP
$2.53B
| $12.1M | 0.5% |
+200,000
| New | +$12.1M |
|
66
Phreesia
PHR
$1.81B
| $11.9M | 0.49% |
565,000
| – | – |
|
|
ODT
67
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $11.9M | 0.49% |
430,000
| – | – |
|
68
NovoCure
NVCR
$1.35B
| $11.8M | 0.49% |
175,000
+2,500
| +1% | +$168K |
|
69
Arvinas
ARVN
$580M
| $11.5M | 0.47% |
285,000
+35,000
| +14% | +$1.41M |
|
70
Health Catalyst
HCAT
$228M
| $11.1M | 0.46% |
425,000
+265,000
| +166% | +$6.93M |
|
|
MNTA
71
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $10.9M | 0.45% |
400,000
| – | – |
|
72
West Pharmaceutical
WST
$17.9B
| $10.8M | 0.45% |
71,000
-81,500
| -53% | -$12.4M |
|
73
FibroGen
FGEN
$48.4M
| $10.6M | 0.44% |
306,000
| – | – |
|
|
ALLK
74
DELISTED
Allakos
ALLK
| $10.5M | 0.43% |
235,000
| – | – |
|
75
CONMED
CNMD
$1.64B
| $10.3M | 0.43% |
+180,000
| New | +$10.3M |
|